Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV open-label study of Jintropin in adults with short bowel syndrome receiving parenteral nutrition support
CTR20243514Phase 4Active
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Start
- Dec 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of somatropin in short bowel syndrome (SBS), sponsored by Changchun GeneScience Pharmaceutical Co., Ltd.. Started Dec 2024; status: active.
02
Drugs
somatropin
03
Conditions
short bowel syndrome (SBS)
Beyond the preview
Go deeper on CTR20243514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243514.